Brian Young - Novanta Chief Human Resource Officer
| 1GSN Stock | EUR 159.00 6.00 3.64% |
Executive
Mr. Brian Young serves as Chief Human Resource Officer of the company. Mr. Young brings more than 20 years of human resources leadership experience in both public and private companies serving Original Equipment Manufacturers of Class I, II III medical devices, industrial control technology and advanced materials. From July 2014 to March 2015, Mr. Young served as Global Human Resource Leader for Hollingsworth Vose Company. From September 2011 to November 2013, Mr. Young served as Vice President Human Resource Officer for CIRCOR International, Inc. From September 2010 to August 2011, Mr. Young served as Director Total Rewards for CIRCOR. In addition, from June 2003 to August 2010, Mr. Young served in various leadership roles with Lake Region Medical . Mr. Youngs early career experience was in General Human Resource Management with a specialization in training and development since 2016.
| Age | 54 |
| Tenure | 8 years |
| Phone | 781 266 5700 |
| Web | https://www.novanta.com |
Brian Young Latest Insider Activity
Tracking and analyzing the buying and selling activities of Brian Young against Novanta stock is an integral part of due diligence when investing in Novanta. Brian Young insider activity provides valuable insight into whether Novanta is net buyers or sellers over its current business cycle. Note, Novanta insiders must abide by specific rules, including filing SEC forms every time they buy or sell Novanta'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Brian Young over six months ago Novanta exotic insider transaction detected | ||
Brian Young over six months ago Payment of 156 shares by Brian Young of Novanta subject to Rule 16b-3 | ||
Brian Young over six months ago Disposition of 351 shares by Brian Young of Novanta subject to Rule 16b-3 | ||
Brian Young over a year ago Exercise or conversion by Brian Young of 2575 shares of Novanta subject to Rule 16b-3 |
Novanta Management Efficiency
The company has return on total asset (ROA) of 0.0534 % which means that it generated a profit of $0.0534 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1392 %, meaning that it generated $0.1392 on every $100 dollars invested by stockholders. Novanta's management efficiency ratios could be used to measure how well Novanta manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0534 |
Novanta Leadership Team
Elected by the shareholders, the Novanta's board of directors comprises two types of representatives: Novanta inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novanta. The board's role is to monitor Novanta's management team and ensure that shareholders' interests are well served. Novanta's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novanta's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephen Bershad, Independent Chairman of the Board | ||
| Ray Nash, Corp Leader | ||
| Michele Welsh, Gen Sec | ||
| Sarah Betadam, Chief Officer | ||
| Deborah Eldracher, Independent Director | ||
| Heinrich Dreyer, Group Vision | ||
| Ira Lamel, Independent Director | ||
| Lonny Carpenter, Independent Director | ||
| Brian King, Independent Director | ||
| Peter Chang, Co Officer | ||
| Brian Young, Chief Human Resource Officer | ||
| Charlie Webster, Ex Chain | ||
| Thomas Secor, Independent Director | ||
| Deborah DiSanzo, Independent Director | ||
| Matthijs Glastra, Chief Executive Officer, Director | ||
| Chuck Ravetto, Group Group | ||
| Robert Buckley, Chief Financial Officer |
Novanta Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Novanta a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0534 | |||
| Current Valuation | 5.53 B | |||
| Shares Outstanding | 35.69 M | |||
| Shares Owned By Insiders | 0.85 % | |||
| Shares Owned By Institutions | 99.15 % | |||
| Price To Earning | 134.04 X | |||
| Price To Book | 9.99 X | |||
| Price To Sales | 5.73 X | |||
| Revenue | 706.79 M |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Novanta Stock
When determining whether Novanta is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Novanta Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Novanta Stock. Highlighted below are key reports to facilitate an investment decision about Novanta Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Novanta. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Novanta Stock please use our How to Invest in Novanta guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .